6-8
Oct
2026
Develco Pharma Schweiz AG
-
Country/Region:Switzerland
-
On CPHI since:2024
Company types
Products from Develco Pharma Schweiz AG (1)
-
Product Develco Pharma Schweiz AG Product List
API Formulation Strength Reference Product Regulatory Status Hydromorphone Immediate release capsule 1.3 - 2.6 mg Palladone® capsule Approved in the EU Prolonged release tablet - twice daily dosing 4 - 8 - 16 - 24 mg Palladone® prolonged release capsule Approved in the EU Prolonged release tablet - once...
